Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Science Advances
|
May 16, 2025
Celluloepidemiology-A paradigm for quantifying infectious disease dynamics on a population level
My K Ha, Anna Postovskaya, Maria Kuznetsova, et al.
BMJ Open
|
March 19, 2024
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
Toon Van Genechten, Maxime De Laere, Jolien Van den Bossche, et al.
Journal of Neuroinflammation
|
October 28, 2025
AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
Leonardo Ricciardi, Federica Di Marco, Marion Decrop, et al.
Redox Report : Communications in Free Radical Research
|
February 18, 2026
DRP1 depletion protects NK cells from hypoxia-induced dysfunction
Tias Verhezen, Astrid Van Den Eynde, Peter Verstraelen, et al.
Journal of Hematology & Oncology
|
February 8, 2024
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, et al.
Blood
|
August 24, 2017
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Sébastien Anguille, Ann L Van de Velde, Evelien L Smits, et al.
Journal of Hematology & Oncology
|
March 20, 2025
Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Zwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Journal of Hematology & Oncology
|
January 24, 2025
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Zwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Science Advances
|
May 16, 2025
Celluloepidemiology-A paradigm for quantifying infectious disease dynamics on a population level
My K Ha, Anna Postovskaya, Maria Kuznetsova, et al.
BMJ Open
|
March 19, 2024
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
Toon Van Genechten, Maxime De Laere, Jolien Van den Bossche, et al.
Journal of Neuroinflammation
|
October 28, 2025
AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
Leonardo Ricciardi, Federica Di Marco, Marion Decrop, et al.
Redox Report : Communications in Free Radical Research
|
February 18, 2026
DRP1 depletion protects NK cells from hypoxia-induced dysfunction
Tias Verhezen, Astrid Van Den Eynde, Peter Verstraelen, et al.
Journal of Hematology & Oncology
|
February 8, 2024
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, et al.
Blood
|
August 24, 2017
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Sébastien Anguille, Ann L Van de Velde, Evelien L Smits, et al.
Journal of Hematology & Oncology
|
March 20, 2025
Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Zwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Journal of Hematology & Oncology
|
January 24, 2025
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Zwi N Berneman, Maxime De Laere, Paul Germonpré, et al.
Page
of 7